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A partially purified protein from the roots of Raphnus sativus (R. sativus) and low-molecular-
weight heparin (LMWH) were tested for their abilities to inhibit the growth of Ehrlich as-
cites carcinoma cells (EAC) intraperitoneally implanted in albino mice. 90 mice were
randomly divided into 6 groups. The antitumor effect of the partially purified protein and
LMWH were assessed by estimating serum transforming growth factor (TGF-b1) and
vascular endothelial growth factor (VEGF). Also, tumor volume, median survival time
(MST), and total lipids, DNA and RNA in liver tissues, liver function tests and the redox
status were estimated. Serum TGF-b1 & VEGF levels were highly significantly increased
(p < 0.005) in the tumorized mice compared to control group and restored to their normal
levels after treatment with LMWH and the purified protein (p < 0.005). Also, the erythro-
cytes content of glutathione (GSH) were showed to be highly significantly decreased
(p < 0.005) in tumorized groups compared to control groups and significantly increased
after treatment with LMWH and the purified protein (p < 0.05). In tumorized mice, the
median survival time (MST) was 12.25 ± 2.5 days, while, MST of tumorized mice treated
with the purified enzyme and LMWH were 19.00 ± 4.69 and 15.75 ± 4.11 days and the in-
crease in life span percent were 155.1% and 128.6% respectively. It can be concluded that,
the partial purified protein from the roots of R. sativus and the LMWH have anti-angiogenic
activity against EAC cells in Swiss albino mice.
Copyright 2014, Mansoura University. Production and hosting by Elsevier B.V. All rights
reserved.1.
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duction of reactive oxygen and a biological system's ability to
readily detoxify the reactive intermediates or easily repair the
resulting damage. Oxidative damage to DNA strands followed
by mutation and alterations in gene expression are the prin-
cipal mechanisms by which ROS contribute to carcinogenesis
[1]. Therefore, protective and beneficial roles of superoxide
dismutase (SOD) have been demonstrated both preclinically
and clinically in combating a broad range of diseases,
including ischemic-reperfusion injury, inflammation, and
cancer [2]. Cells are normally able to defend themselves
against ROS damage through the use of enzymes such as SOD
and catalases. The SODs are found in prokaryotes and eu-
karyotes, where they catalyze the disproportionation of the
superoxide radical anion (O.2) in cellular processes detoxi-
fying reactive oxygen species [3].
SOD, an enzyme that catalyzes the degradation of O.2 to
oxygen and hydrogen peroxide, was discovered approxi-
mately 40 years ago. SOD was presumably the most potent
anti-ROS and was initially thought to be potentially a dream
drug. In humans three SOD enzymes exist, SOD1 is a cyto-
plasmic Cu/Zn-SOD, SOD2 is a mitochondrial Mn-SOD and
SOD3 is an extracellular Cu/ZnSOD. Many studies report the
purification of Mn-SOD from animal blood and plants like
watermelon, pea, garlic and pearl millet [4]. The tumor cells
were inhibited by the addition of these exogenous isolated
Mn-SODs[4]. Manganese superoxide dismutase (Mn-SOD) is
one of the major enzymes responsible for the defense against
oxidative damage due to ROS in the mitochondria [5].
Raphnus sativus (R. sativus) is an annual herb, consumed as
vegetable. It belongs to the family Brassicaceae. It has been
used in folk medicine as a natural drug against many toxi-
cants. It decreases blood glucose levels in diabetic rats [6] and
improves the histopathology of colon mucosa in the rats fed
high fat diet [7]. Recently, Habib and Othman reported that
SOD from Raphnus sativa upregulate erythrocytes glucose up-
take in diabetic patients [8]. Radish extract improves the
antioxidant status of malemice and can overcome or, at least,
significantly diminish mycotoxin (Zearalenone) effects [9].
Heparin and low molecular weight heparin (LMWH) are
commonly used for the prevention or treatment of thrombo-
embolic complications in cancer patients [10]. Based on earlier
observations linking the anticoagulant therapy with heparin
to an improved survival of cancer patients, several prospec-
tive clinical trials were launched with the aim to test heparin
as a potential anticancer treatment [11]. Preclinical analysis of
heparin provides evidence for its anti-metastatic activity in a
variety of animal models [12]. Heparin is a member of a class
of acidic polysaccharides called glycosaminoglycans and
consists of alternating residues of uronic acid and hexos-
amine covalently bound to serine residues of the serglycin
core protein [13].
In addition, tumor inhibition by different low molecular
weight heparins (LMWH) has also been studied [14]. Experi-
mental evidence from various animal models consistently
supports the ability of heparin to attenuate metastasis.
Moreover, this protective effect was not the result of aninhibition of the growth of primary tumors, but rather the
prevention of the spreading of cancer through metastases.
Therefore, the goal of that research was to study the anti-
cancer and anti-metastasis effect of the SOD-like activity
enzyme (natural protein partially purified from R. sativa)
compared with low molecular weight heparin (Fraxiparine,
MW 4.5 KDa) on EAC-bearing mice.2. Materials & methods
2.1. Preparation of R. sativus extract
About 300 g of root tissues of R. sativus were homogenized
with 1 L ice-cold tris buffer pH 7. The resulted supernatantwas
precipitated with 80% ammonium sulfate and the precipitated
protein was passed through calcium phosphate gel, which
then eluted with serial concentrations of NaCl solutions. The
protein after elution with 0.4 and 0.8 M saline solution was
dialyzed against distilled water and then concentrated using
polyethylene glycol. The concentrated partially purified
enzyme was reconstituted with Tris buffer and applied onto
sephadex G100 column. The purified protein concentration
and its SOD activity were assayed according the methods of
Lowry et al. [15] and DeChatelet et al. [16] respectively.
2.2. Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDSePAGE) of the purified enzyme
Protein sample was mixed with 20 ml of SDSePAGE loading
buffer (250 mM TriseHCl, 10% SDS, 0.5% bromophenol blue,
50% glycerol pH 6.8), and incubated at 100 C for 5 min. The
samples were loaded on a 10% SDSepolyacrylamide gel. The
gel was stained with Coomassie blue and inspected visually
for protein bands [17].
2.3. Animals and tumor cell line
All experiments were performed on adult female Swiss albino
mice purchased from Theodore Bilharz Research Institute,
Giza, Egypt, with an average body weight of 25e30 g. Mice
were housed in steel mesh cages (10mice/cage) and main-
tained for two weeks acclimatization period on commercial
standard diet and tap water. The mice were randomly divided
into 6 groups (10 animals each), according to the following
scheme:
Group I: Normal mice saline-treated group (control): Each
mouse was intraperitoneally injected with daily 200 ml of the
physiological saline solution for 10 days.
Group II: Normal mice-treated with the purified SOD: Healthy
mouse treated intraperitoneally for ten days with a daily dose
of 200 ml purified protein (4 mg/kg BW/day) [18].
Group III: Normal mice-treated with low molecular weight hep-
arin (LMWH): Healthy mouse treated intraperitoneally for ten
days with a daily dose of LMWH (fraxiparine, average MW
4.5 KDa) was obtained from Glaxo Smith Kline (Brentford,
Middlesex, UK) (1000 IU/Kg/BW/day [19]) in 200 ml.
Group IV: EAC-bearing mice saline treated: Each mouse was
intraperitoneally injected once with 1x106 tumor cells. After
Fig. 1 e SDS-PAGE for the Raphnus sativa extract (lane 1)
and prestained broad range protein marker (marker) and
standard SOD-enzyme (lane 2).
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injected with daily 200 ml of the physiological saline solution
for 10 days.
Group V: EAC-bearing mice treated with the purified SOD: Each
mouse inoculated intraperitoneally with 1 x 106 tumors cells,
after 24 h treated intraperitoneally for 10 days with a daily
dose of (200 ml) purified protein (4 mg/kg BW/day).
Group VI: EAC-bearing mice treated with low molecular weight
heparin: Each mouse inoculated intraperitoneally with 1  106
tumors cells, after 24 h treated intraperitoneally for 10 days
with a daily dose of LMWH (fraxiparine) (1000 IU/Kg/BW/day).
2.4. Samples
One day after the last treatment, ten mice of each group were
sacrificed & the other 5 mice of each group remain for deter-
mination of the median survival time. The ascetic fluids
containing EAC cells were collected and their volumes were
measured. Liver samples were quickly dissected, rinsed with
isotonic saline and dried. 0.25 g of these tissues was homog-
enized in ice cooled saline and diluted to yield a 5% (w/v). The
supernatants were used for biochemical analysis. Blood
samples were also collected by cardiac puncture from deeply
ether anaesthetized mice and their sera were used for sub-
sequent analysis.
2.5. SOD-like activities of the purified enzyme
SOD-like activities of the different concentrations of the pu-
rified protein were assayed by the method of DeChatelet et al.
[20].
2.6. EAC cells cytotoxicity in vitro
The cytotoxicity was determined using trypan blue exclusion
by themethod ofMaclimans et al. [26]. After treatmentwith the
purified protein and the LMWH, 0.2ml of 0.32% trypan bluewas
mixed with 0.2 ml of EAC cells and incubated for 10 min at
37 C. The number of viable tumor cells, unstained cells, was
countedwithin 5 min after incubation using a homocytometer.
2.7. Determination of median survival time (MST) and
increase in life span (ILS %)
The mortality was monitored by recording percentage in-
crease in life span andmedian survival time by the method of
Gupta et al. [21].
2.8. Biochemical tests
According to the method of Schneider [22], nucleic acids were
extracted from liver homogenate. DNA content was deter-
mined colorimetrically in the extract using diphenylamine
procedure described by the method of Dische and Schwatez
[23] and RNA content was measured by the orcinol procedure
described by the method of Mejbaum [24]. Total lipids in liver
tissues were determined by the method of Knight et al. [25].
Serum Alanine transaminase (ALT) was colorimetrically
determined by themethod of Reitman and Frankel [26]. Serum
albumin concentration was determined by the method ofDoumas [27]. Erythrocyte reduced glutathione (GSH) content
was determined by the method of Beutler et al. [28]. Malon-
dialdehyde (MDA) level was determined in the blood by the
method of Stocks and Donnandy [29]. Superoxide dismutase
(SOD) activity in serum was assayed by the method of
DeChatelet et al. [30]. Serum alkaline phosphatase (ALK-P)
activity was determined by the method described by El-Aaser
and EL-Merzabani [31]. Serum Gamma-glutamyl transferase
(g-GT) activity was determined by the method of Szasz et al.
[32]. Nitric oxide (NO) activity was estimated in serum by the
method of Berkels et al. [33] using a commercially available
assay kit (Egyptian American Company for laboratory ser-
vices, Egypt). TGF-b1 was assayed using a commercially
available assay ELISA kit (Sigma Aldrich, USA). VEGF was
assayed using a commercially available assay ELISA kit (Sigma
Aldrich, USA) following manufacturer's guidelines.
2.9. Statistical analysis
The statistical analyses of the results were carried out using
Instate software computer program, version 2.03 (Graph pad,
USA). The one tailed p-values tables were used for statistical
analysis. A difference was said to be significant, and highly
significant, when the corresponding level of probability (p)
was 0.05 and 0.005, respectively. Correlation coefficient (r)
was used for measuring the relationship between two vari-
ables. The correlation is weak at r ¼ 0.50, moderate at
r ¼ 0.50e0.75 and strong at r ¼ 0.80e1.00.3. Results
R. sativa extract shows a protein concentration of 52.5 mg/
100 ml extract, several protein fractions are seen in the elec-
tropherogram of R. sativa extract and an expected Mn-sod
enzyme with a molecular mass of 25 KDa was detected [5] as
shown in Fig. 1.
The in vitro study reveals that the partial purified protein
has SOD-like activity and its activity increasedwith increasing
Table 1 e In vitro SOD-like activities and cytotoxicity of
the partial purified protein (52.2 mg protein/100 mL) and
LMWH (IU) against EAC-cells.
Conc.
(ml/mg)
SOD
(% inhibition)
Cytotoxicity%
of SOD
Cytotoxicity%
of LMWH
50 mL/mg 69.4% 70.6% 51.5%
100 mL/mg 89.8% 85.0% 67.2%
150 mL/mg 96.2% 98.8% 79.0%
200 mL/mg 98.0% 99.1% 86.8%
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the extract solution. Also, the cytotoxicity of that protein and
LMWH on viable EAC cells is tested The percentages of dead
cells increased with increasing the concentration of the
enzyme and LMWH and reached 99% and 86% respectively
(Table 1).
DNA and RNA contents in liver tissues of untreated EAC-
bearing mice (group IV) are highly significantly elevated
(p < 0.005) compared to the corresponding control (group I).
However, the levels of total lipids are highly significantly
decreased (p<0.005) in liver tissuesof the samegroupcompared
to those of the control. These parameters restored its normal
levels (p < 0.005) after treatment with the partial purified SOD
likeactivityproteinandLMWH(groupsVandVI) (Fig. 2). InTable
2, SOD activity in serum of the treatedmice (groups V and VI) is
highly significant (p < 0.005) increased than normal and
tumorized untreated groups (I, II, III and IV). However, the levels
of nitric oxide (NO) in sera and MDA in RBCs of untreated EAC-
bearing (group IV) are highly significant increased (p < 0.005),
however erythrocytes GSH content is highly significantly
decreased (p < 0.005) than the corresponding controls. These
parametersmaintained itsnormalvalueswhentreatedwith the
SOD extract and LMWH (groups V and VI).
In untreated EAC-bearing mice (group IV), the total ascetic
volume and serum levels of (TGF-b1) and (VEGF) are highly
significantly elevated (p < 0.005) compared to those of the
controls. These values return to the normal levels (p < 0.005)
after treatment with SOD extract and LMWH (groups V and VI)
(Table 3).
In Fig. 3, the serum albumin level is highly significantly
decreased (p< 0.005) in untreated EAC-bearingmice compared
to that of the control. However, the activities of g-GT, ALP and
SGPT in serum of that group are much elevated than that of
the controls. The activities of g-GT, ALP and SGPT remain
within normal value after treatment with SOD extract and
LMWH (groups V and VI). In untreated EAC-bearing mice, the
median survival time (MST) was 12.25 ± 2.5 days, while, the
median survival time of EAC-bearing mice treated with the
purified enzyme and LMWHwere 19.00 ± 4.69 and 15.75 ± 4.11
days and the increase in life span percent were 155.1% and
128.6% respectively (Table 4). Table 5 shows the different
correlations between the different parameters in all groups.4. Discussion
The present work aimed to study the potent effects of a pro-
tein partially purified from R. Sativus roots and low molecular
weight heparin (fraxiparine) on TGF-b1 and VEGF in EAC-bearing mice. The Ehrlich tumor was initially described as
spontaneous murine mammary adenocarcinoma. It is a
rapidly growing carcinoma with very aggressive behavior and
is able to grow in most strains of mice. In ascetic form, it has
been used as transplantable tumor model to investigate the
antitumor effect of several substances [34].
In the present study, the partial purified protein showed
high SOD-like activities (about 98% inhibition) as shown in
(Table 1). Such results confirm the tendency of such protein to
consume O2$ radical produced during photosensitization and
act as free radical scavengers. Ben Salah-Abbes reported that,
the extract of radish contains many antioxidant compounds
that protect against the toxicity resulting from mycotoxin
(Zearalenone) [35]. In addition, the in-vitro cytotoxic activity of
natural protein and heparin against EAC cell lines explains its
significant antitumor activity against ascites as shown in
(Table 1).
In contrast, the levels of total lipids in liver tissues of
groups V and VI showed high elevation after treatment as
shown in Fig. 2, which confirms that, these materials prevent
tumor growth and metastases.
The present study showed higher levels of RNA and DNA
and total volume of ascetic fluid in EAC-bearing mice
compared to the corresponding controls. These elevations
accompanied by a decrease in levels of total lipids compared
to the control (Fig. 2), confirming the existence of a catabolic
state accompanying the growth of the tumor cells [36]. This
increase in DNA and RNA levels and high replication of the
tumor cells needs high energy; so tumor cell growth is usually
consuming the energy sources including lipids and proteins.
These explanations are confirmed by the established negative
correlation between DNA and both total lipids and albumin
(Table 5). Habib et al. reported that, the tumor cell growth
requires high energy, therefore the catabolic effect of the
tumor cell negatively correlated with the total lipids in liver
tissues of the tumorized mice [8]. After treatment with the
partially purified protein, these parameters restored their
normal levels (groups V and VI) by inhibiting the tumor DNA
synthesis [37]. These results agree with the results of Esmat
[38]. In EAC-bearing hosts, regular rapid increase in ascetic
fluid volume was observed. The ascetic fluid is the direct
nutritional source for tumor cells, and the faster increase in
ascites fluid with tumor growth could possibly be a mean to
meet the nutritional requirements of tumor cells [39]. The
results of the present study confirm the previous finding in
that the rate of the tumor growthwas significantly inhibited in
the tumorized mice after treatment with the natural extract
and heparin as shown in Fig. 2.
Glutathione, a potent inhibitor of neoplastic process, plays
an important role as an endogenous antioxidant system that
is found particularly in high concentration in liver and is
known to have key function in the protective process [40]. In
the present study, the mean levels of GSH were significantly
elevated in EAC-bearing mice treated with the natural SOD-
like activity protein and heparin compared to those of EAC-
bearing untreated mice (p < 0.05), indicating that the used
material can be implicated in the redox cycle involved in GSH
production [41]. Reduced glutathione is central to the cellular
antioxidant defenses and acts as an important cofactor for
antioxidant enzymes [42].
Fig. 2 e Total Lipids, DNA and RNA contents in liver tissues of mice of groups (I e VI). (*) Significant (p < 0.05) (**) highly
significant (p < 0.005) compared to group GI. (a) Significant (p < 0.05) (aa) highly significant (p < 0.005) compared to group GIV.
(b) Significant (p < 0.05) (bb) highly significant (p < 0.005) compared to group II. (c) Significant (p < 0.05) (cc) highly significant
(p < 0.005) compared to group III. Group I: Normal mice saline-treated (control): Group II: Normal mice-treated with the
partial purified SOD: Group III: Normal mice-treated with low molecular weight heparin (LMWH): Group IV: EAC-bearing
mice saline treated: Group V: EAC-bearing mice treated with the purified SOD: Group VI: EAC-bearing mice treated with low
molecular weight heparin.
e g y p t i a n j o u r n a l o f b a s i c a n d a p p l i e d s c i e n c e s 1 ( 2 0 1 4 ) 8 8e9 692MDA, the end product of lipid peroxidations was reported
to be higher in carcinomatous tissue than that in the non
diseased organs. The level of MDA reflects the extent of
membrane lipid peroxidation and hence cell membrane
damage and correlated with advanced clinical stages and the
impairment is related to tumor progression. Moreover, it has
been claimed that MDA acts as a tumor promoter and co-
carcinogenic agent because of its high cytotoxicity and
inhibitory action on protective enzymes. Low levels of MDA
indicate inhibition of lipid peroxidation. The biochemical
determination of MDA serves to indicate lipid peroxide for-
mation. Zhang et al., reported that, low-molecular-weight
heparin (LMWH) could significantly decrease MDA content
and increase SOD activity in ischemic brain [43]. It is clear
from this study that R. Sativa inhibits lipid peroxidation and
provides protection by strengthening the antioxidants effect
by glutathione [44].Table 2 e SOD activity and blood levels of GSH, nitric oxide, an
Parameters
group
MDA (Mole/1 ml RBCs)1000 Nitric oxid
(NO) mmol/
G I 4.38 ± 1.256 43.3 ± 5.2
G II 4.73 ± 1.62 41.2 ± 6.1
G III 5.58 ± 0.71 44.3 ± 5.6
G IV 7.99 ± 1.17** 91.3 ± 5.0**
G V 5.56 ± 1.24a 65.0 ± 7.5aa,
G VI 5.40 ± 1.47a 71.5 ± 6.9aa,
The results represented as M ± SD Number of mice ¼ 9.
(*) Significant (p < 0.05) (**) highly significant (p < 0.005) compared to grou
(ª) Significant (p < 0.05) (ªª) highly significant (p < 0.005) compared to grou
(b) Significant (p < 0.05) (bb) highly significant (p < 0.005) compared to gro
(c) Significant (p < 0.05) (cc) highly significant (p < 0.005) compared to grou
Group I: Normal mice saline-treated (control):
Group II: Normal mice-treated with the partial purified SOD:
Group III: Normal mice-treated with low molecular weight heparin (LMW
Group IV: EAC-bearing mice saline treated:
Group V: EAC-bearing mice treated with the purified SOD:
Group VI: EAC-bearing mice treated with low molecular weight heparin.One mechanism that macrophages use to exert their
cytostatic and cytolytic effects on the target tumors is by the
release of nitric oxide (NO) by the activation of the cytosolic,
NADPH-dependent enzyme inducible NO synthase (iNOS) [50].
In the present study, EAC-bearing mice showed a highly sig-
nificant elevation in nitric oxide (NO) level compared to
normal mice. In contrast, EAC-bearing mice treated with the
natural SOD-like activity protein and LMWH showed a highly
significant reduction in nitric oxide (NO) level compared to
EAC-bearing untreated mice. Such results confirm the ten-
dency of the natural purified protein and LMWH to reduce the
cytotoxicity effect of EAC cells. In the present study, EAC-
bearing mice treated with natural SOD-like activity protein
showed an increase of 155.1% in their life span and those
treated with the low molecular weight heparin showed an
increase of 128.5% compared to the tumorized untreated mice
(Table 4).d MDA in RBCs of mice of groups (I e VI).
e
L
GSH (ml Mole/liter RBCs)  1000 SOD
(inhibition %)
2711.5 ± 605.4 39.2 ± 11.8
2624.1 ± 765.3 56.0 ± 7.7*
2765.9 ± 444.9 49.3 ± 5.3
1165.2 ± 580.9** 40.2 ± 8.4
bb 2009.2 ± 365.3ª 82.1 ± 3.8aa,bb
cc 2040.9 ± 236.1a,c 74.3 ± 9.5aa,cc
p GI.
p GIV.
up II.
p III.
H):
Table 3eTotal ascetic volume and serum levels of TGF-b1
and VEGF in mice of groups (I e VI).
Parameters
group
Ascetic
volume (ml)
VEGF (pg/ml) TGF-b1 (pg/ml)
G I e 122.2 ± 24.7 102.7 ± 12.4
G II e 122.3 ± 24.0 115.6 ± 21.5
G III e 127.5 ± 31.3 105.4 ± 15.5
G IV 8.1 ± 1.4 720.2 ± 26.4** 568.6 ± 28.8**
G V 0.8 ± 0.7aa 273.7 ± 65.6aa, bb 233.0 ± 44.9aa, bb
G VI 2.0 ± 2.1aa 337.6 ± 60.9aa, cc 296.4 ± 49.7aa, cc
The results represented as M ± SD Number of mice ¼ 9.
(*) Significant (p < 0.05) (**) highly significant (p < 0.005) compared to
group GI.
(ª) Significant (p < 0.05) (ªª) highly significant (p < 0.005) compared to
group GIV.
(b) Significant (p < 0.05) (bb) highly significant (p < 0.005) compared to
group II.
(c) Significant (p < 0.05) (cc) highly significant (p < 0.005) compared to
group III.
Group I: Normal mice saline-treated (control):
Group II: Normal mice-treated with the partial purified SOD:
Group III: Normal mice-treated with low molecular weight heparin
(LMWH):
Group IV: EAC-bearing mice saline treated:
Group V: EAC-bearing mice treated with the purified SOD:
Group VI: EAC-bearing mice treated with low molecular weight
heparin.
Table 4 e Median survival time of treated and untreated
EAC-bearing mice.
Group Median survival
time (Day)
Percentage increase
of life span
Tumor 12.25 ± 2.5 ………
Treated (SOD) 19.00 ± 4.69 155.1%
Treated (H) 15.75 ± 4.11 128.5%
Values are expressed as mean ± SD (n ¼ 5).
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tumor cells are involved in the promotion of angiogenesis [45].
Furthermore, several of the steps in the development of
angiogenesis can be suppressed by UFH (UnFractionated
Heparin), LMWH, and non-anticoagulant molecules [46]. The
complex interactions of these various mechanisms were
recently reviewed by Ruf [47]. Thus prominent roles in
angiogenesis involve the release of growth factors such as
VEGF (VascularEndothelial Growth Factor) [47].
The suppression of angiogenesis has been promoted as one
of the mechanisms whereby anticoagulants such as UFH and
LMWH may suppress tumor growth and metastasis. In
experimental models assessing endothelial capillary tubeFig. 3 e Serum levels of albumin and Serum activities of ALT, AL
(**) highly significant (p < 0.005) compared to group GI. (a) Signifi
group GIV. (b) Significant (p < 0.05) (bb) highly significant (p < 0.0
significant (p < 0.005) compared to group III. Group I: Normal m
with the partial purified SOD: Group III: Normal mice-treated w
bearing mice saline treated: Group V: EAC-bearing mice treated
with low molecular weight heparin.formation and cell proliferation in cultures have shown that
UFH and various LMWHs can suppress angiogenesis, although
not all to the same extent [48]. Ratner reported an association
of thrombosis with the anti-angiogenic therapy which further
highlights the complex interaction of angiogenesis with the
hemostatic system [49].
Ghosh et al. indicated that tumor volume and its growth
rate increase with increasing angiogenesis and VEGF level of
the host and the rate of VEGF secretion is positively correlated
well with tumor volume [50]. The present results agree with
these observations. After treatment, the tumorized mice
which were treated with the partial purified protein with SOD
like activity andLMWH (groups V and VI),VEGF levels showed a
highly significant decrease compared to that of the tumorized
untreated mice. The latter result confirms the anti-angiogenic
properties of the LMWH in addition to their antithrombotic
properties. This is because short heparin fragments have been
shown to inhibit the binding of VEGF to its receptors on
endothelial cells[51].
TGF-b1 (Transforming growth factor-b1), is a multifunc-
tional cytokine that regulates cell proliferation, differentiation
and extracellular matrix production [52]. Also, TGF-b1 may
contribute to tumor pathogenesis by direct support of tumor
growth and influence on local microenvironment, resulting in
immunosuppression for all cells of the immune system, in-
duction of angiogenesis, and modification of the extracellular
matrix [53]. Vozenin-Brotons et al. reported that, SOD could
significantly reduce TGF- b 1 expression, thus demonstrating
that SOD might be proposed as a potent antagonist of thisP and g-GT in mice of groups (I e VI). (*) Significant (p < 0.05)
cant (p < 0.05) (aa) highly significant (p < 0.005) compared to
05) compared to group II. (c) Significant (p < 0.05) (cc) highly
ice saline-treated (control): Group II: Normal mice-treated
ith low molecular weight heparin (LMWH): Group IV: EAC-
with the purified SOD: Group VI: EAC-bearing mice treated
Table 5 e Correlations between the different parameters of mice of groups (I e VI).
Parameters GSH SGPT g-GT Alb Tumor volume Total lipid NO
DNA (mg/gm tissue) r ¼ 0.63
p < 0.0001
r ¼ 0.9
p < 0.0001
r ¼ 0.72
p < 0.0001
r ¼ 0.81
p < 0.0001
r ¼ 0.77
p < 0.0001
r ¼ 0.55
p < 0.0001
r ¼ 0.88
p < 0.0001
MDA (Mole/1 ml RBCs) r ¼ 0.30
p < 0.05
r ¼ 0.58
p ¼ 0.0001
r ¼ 0.65
p < 0.0001
r ¼ 0.51
p < 0.001
r ¼ 0.61
p < 0.05
Ns r ¼ 0.54
p < 0.001
VEGF (pg/ml) r ¼ 0.69
p < 0.0001
r ¼ 0.84
p < 0.0001
r ¼ 0.88
p < 0.0001
r ¼ 0.82
p < 0.0001
r ¼ 0.93
p < 0.0001
r ¼ 0.52
p < 0.0001
r ¼ 0.91
p < 0.0001
Albumin (g/dl) r ¼ 0.72
p < 0.0001
r ¼ 0.65
p < 0.0001
r ¼ 0.71
p < 0.0001
……
……
r ¼ 0.86
p < 0.0001
r ¼ 0.41
p < 0.05
r ¼ 0.84
p < 0.0001
(p) Probability, (r) correlation coefficient.
Significant (p  0.05), highly significant (p  0.001).
Correlation is considered weak at r ¼ 0.50, moderate at r ¼ 0.50e0.75 and strong at r ¼ 0.80e1.00.
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b1 was highlysignificantly elevated in EAC-bearing mice
compared to normal mice (Table 3). However, after treatment
asin groups V and VI, TGF-b1 level was highly significantly
decreased compared to that of the tumorized untreated mice.
These results confirm the abilities of the LMWH and the nat-
ural SOD-like activity protein to downregulate the level of
TGF-b1 and reduce the growth and metastasis of EAC cells.
In the present results, the activities of GPT, ALP and g-GT
were highly increased in the sera of the untreated EAC-
bearing mice and the level of albumin was decrease (Fig. 3).
The reduction in the activities of both g-GT and SGPT after
treatment with both natural SOD-like activity protein and
LMWH compared with those of the tumorized untreated mice
can confirm the anti-tumor effect of the twomaterials. Similar
to that, reduction of the activities of the all elevated enzymes
(p < 0.005) to near normal levels in animals treated with both
Jasminum sambac and 5'fluorouracil were observe [55].
Most experimental models and cell culture studies have
concluded that SOD has anti-proliferative and tumor sup-
pressor effects [56]. This may be one of the mechanisms by
which R. sativus extract kill the EAC cell line. Furthermore, El-
Sayed reported that, SOD activity was enhanced after treat-
ment of the tumor cells with metal complexes having SOD-
like activity, such type of treatment expresses excessive
amount of H2O2 which implicated in EAC cell killing but not
the normal cell because the latter cell contains sufficient
catalase and/or peroxidase activities to degrade H2O2 [57].
Also, the use of substances with SOD-like activities can cause
a pronounced activation of blood phagocytes.Moreover, Habib
et al. extracted a similar metalloprotein with MnSOD-like ac-
tivity from the roots of R. sativus and showed that, such
extract can activate the immune system to kill the EAC cell
line [58].
Liu et al., showed the effects of heparinesuperoxide dis-
mutase conjugate (heparineSOD) on carbon tetrachloride
(CCl4)-induced acute liver failure and hepatic fibrosis.
Biochemical indicators, such as glutamic pyruvic trans-
aminase (SGPT), GSH (glutathione), and malondialdehyde
(MDA) were determined 24 h after CCl4 treatment. The
development of CCl4-induced acute liver failure altered the
redox state with a decreased hepatic GSH and increased
formation of lipid peroxidative products, which were
partially normalized by treatment with heparineSOD or
heparin þ SOD. Compared with non-treated groups, the acuteliver injury of heparineSOD group was significantly reduced
activities of SGPT, MDA, and increased activities of GSH. Also,
in the present study, level of MDA & SGPT were elevated and
the level of erythrocyte GSH reduced in the tumorized mice,
while after treated with the partially purified extract and low
molecular weight heparin, these parameter were partially
normalized [59].
Natural SOD-like activity protein is economical and of low
toxicity and this is perhaps the advantage over synthetic
agents which exhibit normal tissue toxicity.5. Conclusion
From the above observations one can conclude that, the
naturally and the partially purified protein from R. sativus
roots and the LMWH (fraxiparine) can be used to inhibits EAC
cell growth possibly by many mechanisms including their
antioxidative and anti-angiogenic effects which was observed
in serum of the tumor bearing mice. The mechanism may
involve protection of the tumor suppressor genes from the
toxic effects of free radicals. Moreover, the role of R. sativus
extract in the enhancement of the immune system function
cannot be neglect.r e f e r e n c e s
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